Fu-Hsiung Su1,2,3, Chyi-Huey Bai3, Thi Nga Le4, Chih-Hsin Muo5, Shih-Ni Chang6,7, Arlene Te1,2, Fung-Chang Sung5,8,9, Chih-Ching Yeh3,10,11,12. 1. Department of Family Medicine, Cardinal Tien Hospital, Fu Jen Catholic University, New Taipei City, Taiwan. 2. School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan. 3. School of Public Health, College of Public Health, Taipei Medical University, Taipei, Taiwan. 4. International Master/PhD Program, College of Medicine, Taipei Medical University, Taipei City, Taiwan. 5. Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan. 6. Big Data Center, China Medical University Hospital, Taichung, Taiwan. 7. The Ph.D. Program for Cancer Biology and Drug Discovery, School of Medicine, China Medical University, Taichung, Taiwan. 8. Department of Health Services Administration, College of Public Health, China Medical University, Taichung, Taiwan. 9. Department of Food Nutrition and Health Biotechnology, Asia University, Taichung, Taiwan. 10. Department of Public Health, College of Public Health, China Medical University, Taichung, Taiwan. 11. Cancer Center, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan. 12. Master Program in Applied Molecular Epidemiology, College of Public Health, Taipei Medical University, Taipei, Taiwan.
Abstract
AIM: Studies evaluating colorectal cancer (CRC) risk associated with chronic hepatitis C virus (HCV) infection are limited. METHODS: In this case-control study, we identify 67,670 CRC cases newly diagnosed from 2005 to 2011 and randomly selected 67,670 controls without HCV and CRC from the same database, frequency matched by age and sex of cases. RESULTS: Results of logistic regression analysis revealed that the adjusted odds ratio (aOR) of CRC was 1.16 (95% confidence interval [CI] = 1.08-1.24, p < 0.001) in association with chronic HCV. The CRC risk was slightly greater for women than for men. The risk decreased with age, with the aOR decreased from 2.26 (95% CI = 1.32-3.87, p = 0.003) in patients under 45 years old to 1.31 (95% CI = 1.10-1.55, p = 0.03) in patients aged 50-59, and 1.10 (95% CI = 1.00-1.22, p = 0.061) in patients aged over 70. CONCLUSIONS: Our findings suggested that patients with chronic HCV infection are at an elevated risk of developing CRC. Our data also imply that the CRC prevention programs are needed to target younger HCV patients.
AIM: Studies evaluating colorectal cancer (CRC) risk associated with chronic hepatitis C virus (HCV) infection are limited. METHODS: In this case-control study, we identify 67,670 CRC cases newly diagnosed from 2005 to 2011 and randomly selected 67,670 controls without HCV and CRC from the same database, frequency matched by age and sex of cases. RESULTS: Results of logistic regression analysis revealed that the adjusted odds ratio (aOR) of CRC was 1.16 (95% confidence interval [CI] = 1.08-1.24, p < 0.001) in association with chronic HCV. The CRC risk was slightly greater for women than for men. The risk decreased with age, with the aOR decreased from 2.26 (95% CI = 1.32-3.87, p = 0.003) in patients under 45 years old to 1.31 (95% CI = 1.10-1.55, p = 0.03) in patients aged 50-59, and 1.10 (95% CI = 1.00-1.22, p = 0.061) in patients aged over 70. CONCLUSIONS: Our findings suggested that patients with chronic HCV infection are at an elevated risk of developing CRC. Our data also imply that the CRC prevention programs are needed to target younger HCV patients.
Authors: Janaki Amin; Gregory J Dore; Dianne L O'Connell; Mark Bartlett; Elizabeth Tracey; John M Kaldor; Matthew G Law Journal: J Hepatol Date: 2006-03-31 Impact factor: 25.083
Authors: William Sievert; Ibrahim Altraif; Homie A Razavi; Ayman Abdo; Ezzat Ali Ahmed; Ahmed Alomair; Deepak Amarapurkar; Chien-Hung Chen; Xiaoguang Dou; Hisham El Khayat; Mohamed Elshazly; Gamal Esmat; Richard Guan; Kwang-Hyub Han; Kazuhiko Koike; Angela Largen; Geoff McCaughan; Sherif Mogawer; Ali Monis; Arif Nawaz; Teerha Piratvisuth; Faisal M Sanai; Ala I Sharara; Scott Sibbel; Ajit Sood; Dong Jin Suh; Carolyn Wallace; Kendra Young; Francesco Negro Journal: Liver Int Date: 2011-07 Impact factor: 5.828
Authors: M L Yu; W L Chuang; S C Chen; C Y Dai; C Hou; J H Wang; S N Lu; J F Huang; Z Y Lin; M Y Hsieh; J F Tsai; L Y Wang; W Y Chang Journal: J Med Virol Date: 2001-09 Impact factor: 2.327
Authors: Alexander Swart; Lucinda Burns; Limin Mao; Andrew E Grulich; Janaki Amin; Dianne L O'Connell; Nicola S Meagher; Deborah A Randall; Louisa Degenhardt; Claire M Vajdic Journal: BMJ Open Date: 2012-10-07 Impact factor: 2.692